Naloxone effectiveness on spontaneous and induced perceptive disorders in migraine.
D000328:Adult; D001828:Body Image; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy*; D009270:Naloxone / Q000627:therapeutic use*; D010423:Pentazocine; D010468:Perceptual Disorders / Q000139:chemically induced / Q000188:drug therapy*; D011897:Random Allocation; D012607:Scotoma / Q000139:chemically induced / Q000188:drug therapy*; D013997:Time Factors
D009270:Naloxone; D010423:Pentazocine